Back
AN2 Therapeutics Stock Price Chart
Sponsored
ANTX
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
44
ANTX
AN2 Therapeutics
Last Price:
$1.36
Seasonality Move:
-47.68%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and ANTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
AN2 Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.36 | Buy |
20-day SMA: | 1.43 | Sell |
50-day SMA: | 1.22 | Buy |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 1.36 | Buy |
20-day EMA: | 1.36 | Buy |
50-day EMA: | 1.3 | Buy |
200-day EMA: | 3.13 | Sell |
AN2 Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 54.44 | Buy |
Chaikin Money Flow: | 331569 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.23 - 1.53) | Buy |
Bollinger Bands (100): | (0.88 - 1.56) | Buy |
AN2 Therapeutics Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for AN2 Therapeutics Stock
Is AN2 Therapeutics Stock a Buy?
-
AN2 Therapeutics share price is 1.40 while ANTX 8-day simple moving average is 1.36, which is a Buy signal.
-
The stock price of ANTX is 1.40 while AN2 Therapeutics 20-day SMA is 1.43, which makes it a Sell.
-
AN2 Therapeutics 50-day simple moving average is 1.22 while ANTX share price is 1.40, making it a Buy technically.
-
ANTX stock price is 1.40 and AN2 Therapeutics 200-day simple moving average is 1.88, creating a Sell signal.
ANTX Technical Analysis vs Fundamental Analysis
Sell
44
AN2 Therapeutics (ANTX)
is a Sell
Is AN2 Therapeutics a Buy or a Sell?
-
AN2 Therapeutics stock is rated a SellThe current AN2 Therapeutics [ANTX] share price is $1.40. The Score for ANTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
AN2 Therapeutics Stock Info
Market Cap:
41.8M
Price in USD:
1.40
Share Volume:
512.4K
AN2 Therapeutics 52-Week Range
52-Week High:
22.22
52-Week Low:
0.87
Sell
44
AN2 Therapeutics (ANTX)
is a Sell
AN2 Therapeutics Share Price Forecast
-
What is the AN2 Therapeutics stock price today?The AN2 Therapeutics stock price is 1.40 USD today.
-
Will ANTX stock go up or go down?AN2 Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is AN2 Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, AN2 Therapeutics is overvalued.
Is AN2 Therapeutics Stock a Buy?
-
AN2 Therapeutics share price is 1.40 while ANTX 8-day exponential moving average is 1.36, which is a Buy signal.
-
The stock price of ANTX is 1.40 while AN2 Therapeutics 20-day EMA is 1.36, which makes it a Buy.
-
AN2 Therapeutics 50-day exponential moving average is 1.30 while ANTX share price is 1.40, making it a Buy technically.
-
ANTX stock price is 1.40 and AN2 Therapeutics 200-day simple moving average is 3.13, creating a Sell signal.
Fundamental Analysis of AN2 Therapeutics
Is AN2 Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and an increase next year of $0.29 per share.
Technical Analysis of AN2 Therapeutics
Should I short AN2 Therapeutics stock?
-
ANTX Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting AN2 Therapeutics is a Buy
-
AN2 Therapeutics Relative Strength Index (RSI) is 54.44, which suggest AN2 Therapeutics is overbought
-
The Bollinger Bands (25) for AN2 Therapeutics is (1.23 - 1.53), which suggest AN2 Therapeutics is a Buy
-
The Bollinger Bands (100) for AN2 Therapeutics is (0.88 - 1.56), which suggest AN2 Therapeutics is a Buy
* AN2 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.